sorafenib,tremelimumab,durvalumab
astrazeneca,pfizer
['hcc', 'himalaya']
himalaya safety data support stride regimen as a global treatment option for uhcc #asco23 #asco2023 #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.